Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
May 31, 2026 41.70M
February 28, 2026 41.68M
November 30, 2025 41.57M
August 31, 2025 41.45M
May 31, 2025 40.99M
February 28, 2025 40.97M
November 30, 2024 40.84M
August 31, 2024 41.00M
May 31, 2024 40.43M
February 29, 2024 40.42M
November 30, 2023 40.22M
August 31, 2023 40.22M
May 31, 2023 39.61M
February 28, 2023 39.61M
November 30, 2022 39.50M
August 31, 2022 39.48M
May 31, 2022 39.17M
February 28, 2022 39.15M
November 30, 2021 39.09M
August 31, 2021 39.02M
May 31, 2021 38.55M
February 28, 2021 38.51M
November 30, 2020 38.33M
August 31, 2020 38.32M
May 31, 2020 38.08M
Date Value
February 29, 2020 38.06M
November 30, 2019 37.99M
August 31, 2019 37.99M
May 31, 2019 37.61M
February 28, 2019 37.59M
November 30, 2018 37.51M
August 31, 2018 37.49M
May 31, 2018 37.22M
February 28, 2018 37.17M
November 30, 2017 37.03M
August 31, 2017 37.03M
May 31, 2017 36.84M
February 28, 2017 36.78M
November 30, 2016 36.50M
August 31, 2016 36.74M
May 31, 2016 36.28M
February 29, 2016 36.22M
November 30, 2015 36.14M
August 31, 2015 36.13M
May 31, 2015 35.90M
February 28, 2015 35.88M
November 30, 2014 35.62M
August 31, 2014 35.50M
May 31, 2014 35.44M
February 28, 2014 35.27M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 1.447B
Penumbra, Inc. 39.39M
Abbott Laboratories 1.730B
Alphatec Holdings, Inc. 152.68M
AtriCure, Inc. 50.86M